Effects of Beta-Blockers on White Blood Cells in Heart Failure Patients
Author Information
Author(s): Farcaş Anca Daniela, Stoia Mirela Anca, Mocan-Hognogi Diana Larisa, Goidescu Cerasela Mihaela, Cocoi Alexandra Florina, Anton Florin Petru, Hernández-Jiménez Macarena
Primary Institution: Iuliu Hatieganu University of Medicine and Pharmacy Cluj-Napoca
Hypothesis
How do different types of beta-blockers influence white blood cell subpopulations and the neutrophil/lymphocyte ratio in heart failure patients?
Conclusion
Both types of beta-blockers had similar rehospitalization rates and improved outcomes in heart failure patients.
Supporting Evidence
- Patients on beta-blockers had lower NT-proBNP and NLR levels compared to those not on beta-blockers.
- Metoprolol treatment was associated with higher lymphocyte counts and lower neutrophil counts.
- Patients treated with carvedilol had increased NLR compared to those treated with metoprolol.
Takeaway
This study looked at how heart failure patients' white blood cells change when they take different beta-blockers, finding that both types help but don't change rehospitalization rates.
Methodology
A prospective study enrolling 330 hospitalized heart failure patients, evaluating their blood and clinical data over a year.
Potential Biases
Potential confounding effects from other medications and treatments for heart failure.
Limitations
Small sample size and uneven representation of beta-blockers.
Participant Demographics
Patients were predominantly older adults, with 52.12% male and a mean age of 64.5 years.
Statistical Information
P-Value
p<0.05
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website